NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Telerehabilitation for Multiple Sclerosis

CompletedNA

Sponsor: University of Cadiz

Conditions: Multiple Sclerosis

Interventions: Telerehabilitation, Exercise program

Countries: Spain

Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.

Eligibility overview

Sex: ALL

Age: 35 Years to 60 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Diagnosis of multiple sclerosis according to the McDonald criteria 2017:
* Age between 35 and 60 years.
* Score on the Expanded Disability Status Scale in Multiple Sclerosis by Kurtzke (EDSS) between 2 and 6 points.
* Patients who do not require assistive devices for home mobility.
* Patients with no changes in disease-modifying treatment in the last 3 months.
* Patients who have understood, completed, and signed the informed consent and the study information sheet.

Exclusion Criteria:

* Patients who have been regularly performing strength exercises for more than 3 months prior.
* Moderate/severe cognitive impairment that may interfere with the understanding and/or execution of the study.
* History of alcohol and/or drug abuse.
* Presence of a relapse and/or treatment with corticosteroids within the four weeks prior to the start of the study.
* Patients with severe comorbidities other than MS that may pose a risk for following the exercise guidelines or for their participation in the study for other reasons.

Locations (1)

Seville, Spain